ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance - Concepedia

Concepedia

Publication | Closed Access

ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance

107

Citations

33

References

2014

Year

Jan Dominik Kuhlmann, Pauline Wimberger, Ágnes Bánkfalvi, Thomas Keller, S Schöler, Bahriye Aktas, Paul Buderath, Siegfried Hauch, Friedrich Otterbach, Rainer Kimmig,

Clinical Chemistry

Abstract

The presence of ERCC1(+)CTC can serve as a blood-based diagnostic biomarker for predicting platinum resistance at primary diagnosis of ovarian cancer.

References

	Year	Citations

Page 1